Sung-Chun Kim’ team (Biois Co. Ltd’s) synthesized HER2 specific RNA aptamers that bind efficiently to HER-positive BT-474 breast cancer cells but not to HER2-negative MDA-MB-231 breast cancer cells [64]. Here, ERBB2 is linked to breast carcinoma.